CYTOMEGALOVIRUS SYNDROME

CYTOMEGALOVIRUS SYNDROME was reported 165 times

CYTOMEGALOVIRUS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma Blocker [EPC] 1 0.0042
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 84 0.0038
2 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 4 0.0012
3 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
4 Antimetabolite Immunosuppressant [EPC] 14 0.0007
5 Nucleoside Analog Antiviral [EPC] 45 0.0005
6 Complement 5a Receptor Antagonist [EPC] 2 0.0003
7 Sulfonamide Antibacterial [EPC] 1 0.0003
8 Antimalarial [EPC] 2 0.0002
9 Antiprotozoal [EPC] 2 0.0002
10 Purine Antimetabolite [EPC] 18 0.0002
11 Calcineurin Inhibitor Immunosuppressant [EPC] 21 0.0002
12 CD52-directed Cytolytic Antibody [EPC] 3 0.0002
13 Human Immunoglobulin G [EPC] 3 0.0001
14 Rifamycin Antibacterial [EPC] 4 0.0001
15 Antirheumatic Agent [EPC] 10 0.0001
16 Lipid-based Polyene Antifungal [EPC] 1 0.0001
17 Complement Inhibitor [EPC] 4 0.0001
18 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
19 Corticosteroid [EPC] 85 0.0001
20 Vitamin A [EPC] 3 0.0001
21 Cholinesterase Inhibitor [EPC] 1 0.0001
22 Azole Antifungal [EPC] 8 0.0001
23 Polyene Antifungal [EPC] 2 0.0000
24 Protease Inhibitor [EPC] 2 0.0000
25 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
26 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
27 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
28 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
29 Prostacyclin Receptor Agonist [EPC] 1 0.0000
30 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
31 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
32 Glycopeptide Antibacterial [EPC] 2 0.0000
33 Topoisomerase Inhibitor [EPC] 2 0.0000
34 CD20-directed Cytolytic Antibody [EPC] 8 0.0000
35 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
36 Alkylating Drug [EPC] 6 0.0000
37 Kinase Inhibitor [EPC] 13 0.0000
38 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
39 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
40 Tetracycline-class Drug [EPC] 1 0.0000
41 Janus Kinase Inhibitor [EPC] 2 0.0000
42 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
43 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
44 Aminosalicylate [EPC] 1 0.0000
45 Vitamin D [EPC] 3 0.0000
46 Expectorant [EPC] 2 0.0000
47 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
48 Vitamin B12 [EPC] 3 0.0000
49 Mood Stabilizer [EPC] 2 0.0000
50 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
51 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
52 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
53 Vitamin C [EPC] 3 0.0000
54 alpha-Adrenergic Blocker [EPC] 1 0.0000
55 Leukocyte Growth Factor [EPC] 1 0.0000
56 Proton Pump Inhibitor [EPC] 4 0.0000
57 Aldosterone Antagonist [EPC] 1 0.0000
58 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
59 Loop Diuretic [EPC] 2 0.0000
60 Platelet Aggregation Inhibitor [EPC] 2 0.0000
61 beta-Adrenergic Blocker [EPC] 1 0.0000
62 Insulin Analog [EPC] 1 0.0000
63 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
64 Tumor Necrosis Factor Blocker [EPC] 1 0.0000